Ad is loading...
CVMIX
Price
$17.70
Change
+$0.02 (+0.11%)
Updated
Nov 22 closing price
RNWFX
Price
$81.24
Change
+$0.05 (+0.06%)
Updated
Nov 22 closing price
Ad is loading...

CVMIX vs RNWFX

Header iconCVMIX vs RNWFX Comparison
Open Charts CVMIX vs RNWFXBanner chart's image
Calvert Emerging Markets Equity I
Price$17.70
Change+$0.02 (+0.11%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$81.24
Change+$0.05 (+0.06%)
VolumeN/A
CapitalizationN/A
CVMIX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CVMIX vs. RNWFX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVMIX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 63B vs. CVMIX (1.37B). RNWFX pays higher dividends than CVMIX: RNWFX (1.51) vs CVMIX (0.90). CVMIX was incepted earlier than RNWFX: CVMIX (12 years) vs RNWFX (23 years). CVMIX is a more actively managed with annual turnover of: 59.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than CVMIX: RNWFX (250) vs CVMIX (1000000). RNWFX (11.63) and CVMIX (11.55) have marching annual gain over last year. RNWFX return over 5 years is better than : 18.28 vs. CVMIX (8.10).
CVMIXRNWFXCVMIX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD8.4667.937107%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B63B2%
Annual Yield % from dividends0.901.5160%
Returns for 1 year11.5511.6399%
Returns for 3 years-14.94-11.11135%
Returns for 5 years8.1018.2844%
Returns for 10 years39.8440.7898%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZM81.202.34
+2.97%
Zoom Video Communications
DC2.250.05
+2.27%
Dakota Gold Corp
ERII15.630.13
+0.84%
Energy Recovery
SRAD17.50N/A
N/A
Sportradar Group AG
CGTX0.44N/A
-0.05%
Cognition Therapeutics